The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Changes of Atrial Natriuretic Peptide System in Rats with Puromycin Aminonucleoside-Induced Nephrotic Syndrome

  • Bae, Eun-Hui (Departments of Internal Medicine, Chonnam National University Medical School) ;
  • Lee, Jong-Un (Departments of Physiology, Chonnam National University Medical School) ;
  • Ma, Seong-Kwon (Departments of Internal Medicine, Chonnam National University Medical School) ;
  • Kim, Soo-Wan (Departments of Internal Medicine, Chonnam National University Medical School)
  • Published : 2009.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Sodium retention is a hallmark of nephrotic syndrome. We investigated whether sodium retention is associated with changes of natriuretic peptide system at different stages (i.e., a sodium retaining stage and a compensatory stage) of nephrotic syndrome. At day 7 after PAN(puromycin aminonucleoside) injection, the urinary excretion of sodium was decreased, along with the development of ascites and positive sodium balance. The plasma and urinary ANP(atrial natriuretic peptide) immunoreactivities were increased. ANP mRNA expression was increased in the heart and kidney, whereas that of NPR(natriuretic peptide receptor)-A and NPR-C mRNA was decreased in the kidney. The expression of NEP was decreased in the kidney. At day 14, urinary excretion of sodium did not differ from the control. The plasma ANP level and heart ANP mRNA expression returned to their control values. The expression of ANP mRNA in the kidney was increased in association with increased urinary ANP immunoreactivities. The expression of NPR-A in the kidney became normal, whereas that of NPR-C kept decreased. The expression of NEP(neutral endopeptidase) remained decreased. These findings suggest that the increased renal ANP synthesis in association with decreased metabolism via NEP and NPR-C may play a compensatory role against the development of sodium retention in nephrotic syndrome. The decreased of NPR-A expression in the kidney may contribute to the ANP resistance at day 7. The subsequent recovery of NPR-A expression may play a role in promoting sodium excretion in later stage(at day 14).

Keywords

References

  1. Deschenes G, Doucet A. Collecting duct Na,K-ATPase activity correlates with urinary sodium excretion in rat nephrotic syndrome. J Am Soc Nephrol 11: 604-615, 2000
  2. Deschenes G, Gonin S, Zolty E, Cheval L, Rousselot M, Martin PY, Verbavatz JM, Feraille E, Doucet A. Increased synthesis and avp unresponsiveness of Na,K-ATPase in collecting duct from nephrotic rats. J Am Soc Nephrol 12: 2241-2252, 2001
  3. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15: 135-162, 1994 https://doi.org/10.1210/edrv-15-2-135
  4. Goetz KL, Wang BC, Geer PG, Leadley RJ, Jr., Reinhardt HW. Atrial stretch increases sodium excretion independently of release of atrial peptides. Am J Physiol 250: R946-R950, 1986
  5. Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephritic syndrome. J Clin Invest 71: 91-103, 1983 https://doi.org/10.1172/JCI110756
  6. Kim SW, Schou UK, Peters CD, de Seigneuxs S, Kwon TH, Knepper MA, Jonassen TE, Frokiaer J, Nielsen S. Increased apical targeting of renal epithelial sodium channel subunits and decreased expression of type 2 11beta-hydroxysteroid dehydrogenase in rats with CCl4-induced decompensated liver cirrhosis. J Am Soc Nephrol 16: 3196-3210, 2005 https://doi.org/10.1681/ASN.2004080721
  7. Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frokiaer J, Nielsen S. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol 286: F922-F935, 2004 https://doi.org/10.1152/ajprenal.00277.2003
  8. Kim SW, Wang W, Sassen MC, Choi KC, Han JS, Knepper MA, Jonassen TE, Frokiaer J, Nielsen S. Biphasic changes of epithelial sodium channel abundance and trafficking in common bile duct ligation-induced liver cirrhosis. Kidney Int 69: 89-98, 2006 https://doi.org/10.1038/sj.ki.5000018
  9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001 https://doi.org/10.1006/meth.2001.1262
  10. Parkes DG, Coghlan JP, McDougall JG, Scoggins BA. Long-term hemodynamic actions of atrial natriuretic factor (99-126) in conscious sheep. Am J Physiol 254: H811-H815, 1988
  11. Perico N, Delaini F, Lupini C, Benigni A, Galbusera M, Boccardo P, Remuzzi G. Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int 36: 57-64, 1989 https://doi.org/10.1038/ki.1989.161
  12. Perico N, Remuzzi G. Edema of the nephrotic syndrome: the role of the atrial natriuretic peptide system. Am J Kidney Dis 22: 355-366, 1993 https://doi.org/10.1016/S0272-6386(12)70137-3
  13. Peterson C, Madsen B, Perlman A, Chan AY, Myers BD. Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans. Kidney Int 34: 825-831, 1988 https://doi.org/10.1038/ki.1988.256
  14. inger DR, Shore AC, Markandu ND, Buckley MG, Sagnella GA, MacGregor GA. Dissociation between plasma atrial natriuretic peptide levels and urinary sodium excretion after intravenous saline infusion in normal man. Clin Sci 73: 285-289, 1987 https://doi.org/10.1042/cs0730285
  15. Valentin JP, Qiu C, Muldowney WP, Ying WZ, Gardner DG, Humphreys NH. Cellular basis for blunted volume expansion natriuresis in experimental ephrotic syndrome. J Clin Invest 90: 1302-1312, 1992 https://doi.org/10.1172/JCI115995
  16. Vande Walle JG, Donckerwolcke RA. Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 16: 283-293, 2001 https://doi.org/10.1007/s004670000512
  17. Wilkins MR, Redondo J, Brown LA. The natriuretic-peptide family. Lancet 349: 1307-1310, 1997 https://doi.org/10.1016/S0140-6736(96)07424-7
  18. Woolf AS, Lyon TL, Hoffbrand BI, Cohen SL, Moult PJ. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome. Nephron 52: 244-250, 1989 https://doi.org/10.1159/000185650